|
The new strategy focuses on making the MHRA’s drug and device regulation more efficient and patient centric with the use of technologies like AI.
|
 |
|
Enodia Therapeutics will handle initial discovery work to identify, refine, and advance small-molecule candidates directed at multiple targets.
|
|
|
The pharma-backed company will now progress three drugs for FSHD, heart failure and muscle & metabolic disorders to the clinic.
|
|
|
The partnership focuses on biologics quality control as well as viral and release testing under cGMP standards.
|
|
|
The Swiss pharma giant now joins a growing list of big pharma and biotech players exploring the RNAi approach’s promise in treating obesity.
|
|
